Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05985135 · ClinicalTrials.gov registry record · NA
Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT05985135: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT05985135 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05985135, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This research is being done to better understand how insulin effects muscle, blood, and the body in people with Type 1 Diabetes.
Interventions
- PROCEDURE Muscle Biopsy
- DIETARY_SUPPLEMENT Dextrose
- OTHER Jell-O with Amino acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05985135
The ClinicalTrials.gov registry entry for NCT05985135 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Muscle Biopsy is the first listed.
NCT05985135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05985135 about?
NCT05985135 is a clinical study titled "Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus". This research is being done to better understand how insulin effects muscle, blood, and the body in people with Type 1 Diabetes.
What is the current status of trial NCT05985135?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-06-01. Estimated completion is 2028-08.
What interventions are being tested in trial NCT05985135?
The interventions under investigation include: Muscle Biopsy (PROCEDURE), Dextrose (DIETARY_SUPPLEMENT), Jell-O with Amino acids (OTHER).
Who is sponsoring clinical trial NCT05985135?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.